| Year |
Citation |
Score |
| 2023 |
Ho K, Zhu D, Gupta K, Loloi J, Abramson M, Watts K, Agalliu I, Sankin A. Performance of cognitive vs. image-guided fusion biopsy for detection of overall and clinically significant prostate cancer in a multiethnic population. Urologic Oncology. PMID 38114350 DOI: 10.1016/j.urolonc.2023.11.005 |
0.352 |
|
| 2023 |
Hoffmann TJ, Graff RE, Madduri RK, Rodriguez AA, Cario CL, Feng K, Jiang Y, Wang A, Klein RJ, Pierce BL, Eggener S, Tong L, Blot W, Long J, Rebbeck T, ... ... Agalliu I, et al. Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves cross-ancestry prediction. Medrxiv : the Preprint Server For Health Sciences. PMID 37961155 DOI: 10.1101/2023.10.27.23297676 |
0.319 |
|
| 2023 |
Patel RD, Zhu M, Dave P, Agalliu I, Trinh QD, Watts KL. Predictors of Timely and Delayed Urological Evaluation Following Referral for Elevated Prostate-specific Antigen in a Diverse, Urban, High-risk Population. Urology Practice. 101097UPJ00000000000. PMID 37103521 DOI: 10.1097/UPJ.0000000000000405 |
0.307 |
|
| 2022 |
Kim MS, Naidoo D, Hazra U, Quiver MH, Chen WC, Simonti CN, Kachambwa P, Harlemon M, Agalliu I, Baichoo S, Fernandez P, Hsing AW, Jalloh M, Gueye SM, Niang L, et al. Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa. Genome Biology. 23: 194. PMID 36100952 DOI: 10.1186/s13059-022-02766-z |
0.44 |
|
| 2022 |
Zhu D, Toker M, Shyr W, Fram E, Watts KL, Agalliu I. Association of Obesity and Diabetes With Prostate Cancer Risk Groups in a Multiethnic Population. Clinical Genitourinary Cancer. PMID 35193833 DOI: 10.1016/j.clgc.2022.01.016 |
0.377 |
|
| 2021 |
Zhu D, Shyr W, Toker M, Fram E, Cheng J, Kovac EZ, Agalliu I, Aboumohamed A, Watts KL. The impact of surgical downgrading on prostate cancer recurrence: systematic review and analysis of a multiethnic population. World Journal of Urology. PMID 34850269 DOI: 10.1007/s00345-021-03892-2 |
0.362 |
|
| 2021 |
Agalliu I, Lin WJ, Zhang JS, Jacobson JS, Rohan TE, Adusei B, Snyper NYF, Andrews C, Sidahmed E, Mensah JE, Biritwum R, Adjei AA, Okyne V, Ainuson-Quampah J, Fernandez P, et al. Overall and central obesity and prostate cancer risk in African men. Cancer Causes & Control : Ccc. PMID 34783926 DOI: 10.1007/s10552-021-01515-0 |
0.371 |
|
| 2021 |
Hines L, Zhu D, DeMasi M, Babar M, Chernyak V, Kovac EZ, Aboumohamed A, Sankin A, Agalliu I, Watts KL. A Comparison of Image-Guided Targeted Prostate Biopsy Outcomes by PI-RADS Score and Ethnicity in a Diverse, Multiethnic Population. The Journal of Urology. 101097JU000000000000. PMID 33881932 DOI: 10.1097/JU.0000000000001810 |
0.319 |
|
| 2021 |
Zhu D, Srivastava A, Agalliu I, Fram E, Kovac EZ, Aboumohamed A, Schoenberg MP, Sankin AI. Finasteride Use and Risk of Bladder Cancer in a Multiethnic Population. The Journal of Urology. 101097JU000000000000. PMID 33617325 DOI: 10.1097/JU.0000000000001694 |
0.306 |
|
| 2020 |
Hurwitz LM, Agalliu I, Albanes D, Barry KH, Berndt SI, Cai Q, Chen C, Cheng I, Genkinger JM, Giles GG, Huang J, Joshu CE, Key TJ, Knutsen S, Koutros S, et al. Recommended definitions of aggressive prostate cancer for etiologic epidemiologic research. Journal of the National Cancer Institute. PMID 33010161 DOI: 10.1093/jnci/djaa154 |
0.391 |
|
| 2020 |
Harlemon M, Ajayi O, Kachambwa P, Kim MS, Simonti CN, Quiver MH, Petersen DC, Mittal A, Fernandez PW, Hsing AW, Baichoo S, Agalliu I, Jalloh M, Gueye SM, Snyper NYF, et al. A custom genotyping array reveals population-level heterogeneity for the genetic risks of prostate cancer and other cancers in Africa. Cancer Research. PMID 32393663 DOI: 10.1158/0008-5472.CAN-19-2165 |
0.43 |
|
| 2020 |
Zahalka AH, Fram E, Lin W, Mohn L, Frenette PS, Agalliu I, Watts KL. Use of beta-blocker types and risk of incident prostate cancer in a multiethnic population. Urologic Oncology. PMID 32307329 DOI: 10.1016/J.Urolonc.2020.03.024 |
0.373 |
|
| 2019 |
Zahalka* A, Fram E, Lin W, Mohn L, Frenette P, Agalliu I, Watts K. MP48-16 ATENOLOL REDUCES INCIDENT LOW AND INTERMEDIATE RISK PROSTATE CANCER Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556400.17034.02 |
0.413 |
|
| 2018 |
Andrews C, Fortier B, Hayward A, Lederman R, Petersen L, McBride J, Petersen DC, Ajayi O, Kachambwa P, Seutloali M, Shoko A, Mokhosi M, Hiller R, Adams M, Ongaco C, ... ... Agalliu I, et al. Development, Evaluation, and Implementation of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate. Journal of Global Oncology. 1-14. PMID 30260755 DOI: 10.1200/Jgo.18.00063 |
0.392 |
|
| 2017 |
Llukani E, Katz BF, Agalliu I, Lightfoot A, Yu SS, Kathrins M, Lee Z, Su YK, Monahan Agnew K, McGill A, Eun DD, Lee DI. Low levels of serum testosterone in middle-aged men impact pathological features of prostate cancer. Prostate International. 5: 17-23. PMID 28352619 DOI: 10.1016/j.prnil.2016.12.003 |
0.353 |
|
| 2016 |
Adedimeji AA, Lounsbury D, Popoola O, Asuzu C, Lawal A, Oladoyin V, Crifase C, Agalliu I, Shankar V, Adebiyi A. Improving outcomes in cancer diagnosis, prevention and control: barriers, facilitators and the need for health literacy in Ibadan Nigeria. Psycho-Oncology. PMID 27218238 DOI: 10.1002/Pon.4158 |
0.329 |
|
| 2015 |
Palma A, Lounsbury DW, Schlecht NF, Agalliu I. A System Dynamics Model of Serum Prostate-Specific Antigen Screening for Prostate Cancer. American Journal of Epidemiology. PMID 26702631 DOI: 10.1093/aje/kwv262 |
0.382 |
|
| 2015 |
Agalliu I, Adebiyi AO, Lounsbury DW, Popoola O, Jinadu K, Amodu O, Paul S, Adedimeji A, Asuzu C, Asuzu M, Ogunbiyi OJ, Rohan T, Shittu OB. The feasibility of epidemiological research on prostate cancer in African men in Ibadan, Nigeria. Bmc Public Health. 15: 425. PMID 25927535 DOI: 10.1186/S12889-015-1754-X |
0.445 |
|
| 2015 |
Agalliu I, Williams S, Adler B, Androga L, Siev M, Lin J, Xue X, Huang G, Strickler HD, Ghavamian R. The impact of obesity on prostate cancer recurrence observed after exclusion of diabetics. Cancer Causes & Control : Ccc. 26: 821-30. PMID 25771797 DOI: 10.1007/s10552-015-0554-z |
0.346 |
|
| 2015 |
Beebe-Dimmer JL, Yee C, Cote ML, Petrucelli N, Palmer N, Bock C, Lane D, Agalliu I, Stefanick ML, Simon MS. Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study. Cancer. 121: 1265-72. PMID 25754547 DOI: 10.1002/Cncr.29075 |
0.466 |
|
| 2013 |
Desai P, Chlebowski R, Cauley JA, Manson JE, Wu C, Martin LW, Jay A, Bock C, Cote M, Petrucelli N, Rosenberg CA, Peters U, Agalliu I, Budrys N, Abdul-Hussein M, et al. Prospective analysis of association between statin use and breast cancer risk in the women's health initiative. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1868-76. PMID 23975947 DOI: 10.1158/1055-9965.Epi-13-0562 |
0.394 |
|
| 2013 |
Schooling CM, Sembajwe G, Agalliu I. Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study. European Urology. 64: e59-60. PMID 23623050 DOI: 10.1016/j.eururo.2013.04.017 |
0.336 |
|
| 2013 |
Agalliu I, Wang Z, Wang T, Dunn A, Parikh H, Myers T, Burk RD, Amundadottir L. Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction. Plos One. 8: e60083. PMID 23573233 DOI: 10.1371/journal.pone.0060083 |
0.403 |
|
| 2013 |
Leenders M, Bhattacharjee S, Vineis P, Stevens V, Bueno-de-Mesquita HB, Shu XO, Amundadottir L, Gross M, Tobias GS, Wactawski-Wende J, Arslan AA, Duell EJ, Fuchs CS, Gallinger S, Hartge P, ... ... Agalliu I, et al. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Cancer Causes & Control : Ccc. 24: 595-602. PMID 23334854 DOI: 10.1007/S10552-012-0138-0 |
0.306 |
|
| 2012 |
Hakimi AA, Agalliu I, Ho GY, Ghavamian R, Yu C, Kattan MW, Rabbani F. Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy. The Journal of Urology. 187: 1234-40. PMID 22335862 DOI: 10.1016/J.Juro.2011.11.090 |
0.405 |
|
| 2012 |
Wang Z, Parikh H, Jia J, Myers T, Yeager M, Jacobs KB, Hutchinson A, Burdett L, Ghosh A, Thun MJ, Gapstur SM, Ryan Diver W, Virtamo J, Albanes D, Cancel-Tassin G, ... ... Agalliu I, et al. Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry. Human Genetics. 131: 1173-85. PMID 22271044 DOI: 10.1007/s00439-012-1139-5 |
0.44 |
|
| 2011 |
Agalliu I, Costello S, Applebaum KM, Ray RM, Astrakianakis G, Gao DL, Thomas DB, Checkoway H, Eisen EA. Risk of lung cancer in relation to contiguous windows of endotoxin exposure among female textile workers in Shanghai. Cancer Causes & Control : Ccc. 22: 1397-404. PMID 21732048 DOI: 10.1007/S10552-011-9812-X |
0.569 |
|
| 2011 |
Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker CH, Ferrell RE, Jackson M, Kidd LC, Kolb S, Lavender NA, McFarlane-Anderson N, Morrison SS, Multigner L, Ostrande EA, Park JY, et al. Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis. 32: 1361-5. PMID 21705483 DOI: 10.1093/Carcin/Bgr119 |
0.466 |
|
| 2011 |
Djavan B, Laze J, Eckersberger E, Finkelstein J, Agalliu I, Lepor H. The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer. Bju International. 108: 1582-7. PMID 21443653 DOI: 10.1111/j.1464-410X.2011.10173.x |
0.354 |
|
| 2011 |
Agalliu I, Kirsh VA, Kreiger N, Soskolne CL, Rohan TE. Oxidative balance score and risk of prostate cancer: results from a case-cohort study. Cancer Epidemiology. 35: 353-61. PMID 21145797 DOI: 10.1016/J.Canep.2010.11.002 |
0.414 |
|
| 2010 |
Agalliu I, Leanza SM, Smith L, Trent JM, Carpten JD, Bailey-Wilson JE, Burk RD. Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population. The Prostate. 70: 1716-27. PMID 20564318 DOI: 10.1002/Pros.21207 |
0.415 |
|
| 2010 |
Jacobs EJ, Chanock SJ, Fuchs CS, Lacroix A, McWilliams RR, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Petersen G, Zheng W, Agalliu I, Allen NE, et al. Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). International Journal of Cancer. Journal International Du Cancer. 127: 1421-8. PMID 20049842 DOI: 10.1002/Ijc.25148 |
0.406 |
|
| 2010 |
Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes & Control : Ccc. 21: 289-300. PMID 19902366 DOI: 10.1007/S10552-009-9461-5 |
0.303 |
|
| 2009 |
Agalliu I, Gern R, Leanza S, Burk RD. Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1112-20. PMID 19188187 DOI: 10.1158/1078-0432.CCR-08-1822 |
0.402 |
|
| 2008 |
FitzGerald LM, Agalliu I, Johnson K, Miller MA, Kwon EM, Hurtado-Coll A, Fazli L, Rajput AB, Gleave ME, Cox ME, Ostrander EA, Stanford JL, Huntsman DG. Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer. Bmc Cancer. 8: 230. PMID 18694509 DOI: 10.1186/1471-2407-8-230 |
0.406 |
|
| 2008 |
Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL. Statin use and risk of prostate cancer: results from a population-based epidemiologic study. American Journal of Epidemiology. 168: 250-60. PMID 18556686 DOI: 10.1093/Aje/Kwn141 |
0.503 |
|
| 2008 |
Agalliu I, Suuriniemi M, Prokunina-Olsson L, Johanneson B, Collins FS, Stanford JL, Ostrander EA. Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study. The Prostate. 68: 740-7. PMID 18302196 DOI: 10.1002/Pros.20732 |
0.511 |
|
| 2008 |
Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR. Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men. Cancer Causes & Control : Ccc. 19: 25-31. PMID 17906959 DOI: 10.1007/S10552-007-9066-9 |
0.496 |
|
| 2007 |
Agalliu I, Karlins E, Kwon EM, Iwasaki LM, Diamond A, Ostrander EA, Stanford JL. Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer. British Journal of Cancer. 97: 826-31. PMID 17700570 DOI: 10.1038/Sj.Bjc.6603929 |
0.457 |
|
| 2007 |
Agalliu I, Weiss NS, Lin DW, Stanford JL. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men. Cancer Causes & Control : Ccc. 18: 931-7. PMID 17641982 DOI: 10.1016/J.Juro.2007.10.044 |
0.471 |
|
| 2007 |
Suuriniemi M, Agalliu I, Schaid DJ, Johanneson B, McDonnell SK, Iwasaki L, Stanford JL, Ostrander EA. Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 809-14. PMID 17416775 DOI: 10.1158/1055-9965.Epi-06-1049 |
0.522 |
|
| 2007 |
Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer. 109: 1192-202. PMID 17311344 DOI: 10.1002/Cncr.22534 |
0.517 |
|
| 2007 |
Agalliu I, Kwon EM, Zadory D, McIntosh L, Thompson J, Stanford JL, Ostrander EA. Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 839-43. PMID 17289875 DOI: 10.1158/1078-0432.Ccr-06-2164 |
0.495 |
|
| 2006 |
Agalliu I, Lin DW, Salinas CA, Feng Z, Stanford JL. Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis. The Prostate. 66: 1535-41. PMID 16921513 DOI: 10.1002/Pros.20491 |
0.455 |
|
| 2006 |
Salinas CA, Agalliu I, Stanford JL, Lin DW. Statins and the risk of cancer. Jama. 295: 2721; author reply 2. PMID 16788124 DOI: 10.1001/Jama.295.23.2721-A |
0.474 |
|
| 2006 |
Agalliu I, Langeberg WJ, Lampe JW, Salinas CA, Stanford JL. Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle-aged men. The Prostate. 66: 146-56. PMID 16173036 DOI: 10.1002/Pros.20305 |
0.483 |
|
| 2005 |
Agalliu I, Kriebel D, Quinn MM, Wegman DH, Eisen EA. Prostate cancer incidence in relation to time windows of exposure to metalworking fluids in the auto industry. Epidemiology (Cambridge, Mass.). 16: 664-71. PMID 16135943 DOI: 10.1097/01.Ede.0000173266.49104.Bb |
0.644 |
|
| 2005 |
Agalliu I, Eisen EA, Kriebel D, Quinn MM, Wegman DH. A biological approach to characterizing exposure to metalworking fluids and risk of prostate cancer (United States). Cancer Causes & Control : Ccc. 16: 323-31. PMID 15953975 DOI: 10.1007/S10552-004-4323-7 |
0.647 |
|
| 2004 |
Eisen EA, Agalliu I, Thurston SW, Coull BA, Checkoway H. Smoothing in occupational cohort studies: an illustration based on penalised splines. Occupational and Environmental Medicine. 61: 854-60. PMID 15377772 DOI: 10.1136/Oem.2004.013136 |
0.532 |
|
| 2003 |
Agalliu I, Eisen EA, Hauser R, Redlich CA, Stowe MH, Cullen MR, Wegman DH, Christiani DC, Kennedy SM. Truncating the dose range for methacholine challenge tests: three occupational studies. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 45: 841-7. PMID 12915785 DOI: 10.1097/01.Jom.0000083031.56116.53 |
0.454 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2017 |
Srivastava A, Fram E, Agalliu I, Schoenberg M, Sankin A. PD57-07 RACE AND FINASTERIDE USE: DIFFERENTIAL IMPACT ON BLADDER CANCER RISK Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2609 |
0.267 |
|
| 2018 |
Hayes RB, Ahn J, Fan X, Peters BA, Ma Y, Yang L, Agalliu I, Burk RD, Ganly I, Purdue MP, Freedman ND, Gapstur SM, Pei Z. Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer. Jama Oncology. PMID 29327043 DOI: 10.1001/Jamaoncol.2017.4777 |
0.266 |
|
| 2018 |
Odiaka E, Lounsbury DW, Jalloh M, Adusei B, Diallo TA, Kane PMS, Rockson I, Okyne V, Irusen H, Pentz A, Makinde I, Ajibola OH, Petersen L, McBride J, Petersen DC, ... ... Agalliu I, et al. Effective Project Management of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate (MADCaP). Journal of Global Oncology. 1-12. PMID 30260756 DOI: 10.1200/Jgo.18.00062 |
0.263 |
|
| 2023 |
Rebbeck T, Janivara R, Chen W, Hazra U, Baichoo S, Agalliu I, Kachambwa P, Simonti C, Brown L, Tambe S, Kim M, Harlemon M, Jalloh M, Muzondiwa D, Naidoo D, et al. Heterogeneous genetic architectures and evolutionary genomics of prostate cancer in Sub-Saharan Africa. Research Square. PMID 37886553 DOI: 10.21203/rs.3.rs-3378303/v1 |
0.259 |
|
| 2022 |
Robbins HA, Ferreiro-Iglesias A, Waterboer T, Brenner N, Nygard M, Bender N, Schroeder L, Hildesheim A, Pawlita M, D'Souza G, Visvanathan K, Langseth H, Schlecht NF, Tinker LF, Agalliu I, et al. Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101785. PMID 35700419 DOI: 10.1200/JCO.21.01785 |
0.255 |
|
| 2012 |
Li D, Duell EJ, Yu K, Risch HA, Olson SH, Kooperberg C, Wolpin BM, Jiao L, Dong X, Wheeler B, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, ... ... Agalliu I, et al. Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis. 33: 1384-90. PMID 22523087 DOI: 10.1093/Carcin/Bgs151 |
0.249 |
|
| 2014 |
Fejerman L, Ahmadiyeh N, Hu D, Huntsman S, Beckman KB, Caswell JL, Tsung K, John EM, Torres-Mejia G, Carvajal-Carmona L, Echeverry MM, Tuazon AM, Ramirez C, Gignoux CR, ... ... Agalliu I, et al. Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25. Nature Communications. 5: 5260. PMID 25327703 DOI: 10.1038/Ncomms6260 |
0.246 |
|
| 2015 |
Agalliu I, San Luciano M, Mirelman A, Giladi N, Waro B, Aasly J, Inzelberg R, Hassin-Baer S, Friedman E, Ruiz-Martinez J, Marti-Masso JF, Orr-Urtreger A, Bressman S, Saunders-Pullman R. Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis. Jama Neurology. 72: 58-65. PMID 25401981 DOI: 10.1001/jamaneurol.2014.1973 |
0.212 |
|
| 2018 |
Agalliu I, Chen Z, Wang T, Hayes RB, Freedman ND, Gapstur SM, Burk RD. Oral Alpha, Beta and Gamma HPV Types and Risk of Incident Esophageal Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30087123 DOI: 10.1158/1055-9965.Epi-18-0287 |
0.208 |
|
| 2021 |
Barry E, Agalliu I, Maiman R, Shreck E, Kovac E, Aboumohamed A, Sankin A. OUTCOMES OF INTRAVESICAL BACILLUS CALMETTE-GUERIN IN A MULTIRACIAL COHORT WITH NON-MUSCLE-INVASIVE BLADDER CANCER. Urology Practice. 8: 100-105. PMID 34017909 DOI: 10.1097/upj.0000000000000154 |
0.19 |
|
| 2021 |
Kim JI, Zhu D, Barry E, Kovac E, Aboumohamed A, Agalliu I, Sankin A. Intravesical Bacillus Calmette-Guérin Treatment Is Inversely Associated With the Risk of Developing Alzheimer Disease or Other Dementia Among Patients With Non-muscle-invasive Bladder Cancer. Clinical Genitourinary Cancer. PMID 34116955 DOI: 10.1016/j.clgc.2021.05.001 |
0.188 |
|
| 2021 |
Schoenfeld D, Zhu D, Mohn L, Di Vito J, Agalliu I, Stern JM. The relationship between vascular calcifications and urolithiasis in a large, multiethnic patient population. Urolithiasis. PMID 33961080 DOI: 10.1007/s00240-021-01268-0 |
0.175 |
|
| 2019 |
Agalliu I, Ortega RA, Luciano MS, Mirelman A, Pont-Sunyer C, Brockmann K, Vilas D, Tolosa E, Berg D, Warø B, Glickman A, Raymond D, Inzelberg R, Ruiz-Martinez J, Mondragon E, et al. Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31348549 DOI: 10.1002/Mds.27807 |
0.167 |
|
| 2022 |
Zhu D, Loloi J, Labagnara K, Schwartz D, Agalliu I, Fram EB, Sankin A, Aboumohamed A, Kovac E. Clinical Risk Factors Associated With Small Renal Mass Malignant Histology in a Multi-Ethnic Population Undergoing Partial Nephrectomy. Clinical Genitourinary Cancer. PMID 35768315 DOI: 10.1016/j.clgc.2022.06.004 |
0.156 |
|
| 2016 |
Agalliu I, Wang T, Burk RD. β- and γ-Human Papillomavirus Types and Smoking in Head and Neck Cancer-Reply. Jama Oncology. 2: 687-688. PMID 27244681 DOI: 10.1001/jamaoncol.2016.0973 |
0.149 |
|
| 2024 |
Janivara R, Hazra U, Pfennig A, Harlemon M, Kim MS, Eaaswarkhanth M, Chen WC, Ogunbiyi A, Kachambwa P, Petersen LN, Jalloh M, Mensah JE, Adjei AA, Adusei B, Joffe M, ... ... Agalliu I, et al. Uncovering the genetic architecture and evolutionary roots of androgenetic alopecia in African men. Biorxiv : the Preprint Server For Biology. PMID 38293167 DOI: 10.1101/2024.01.12.575396 |
0.143 |
|
| 2016 |
Agalliu I, Gapstur S, Chen Z, Wang T, Anderson RL, Teras L, Kreimer AR, Hayes RB, Freedman ND, Burk RD. Associations of Oral α-, β-, and γ-Human Papillomavirus Types With Risk of Incident Head and Neck Cancer. Jama Oncology. PMID 26794505 DOI: 10.1001/Jamaoncol.2015.5504 |
0.143 |
|
| 2013 |
Agalliu I, Xue X, Cushman M, Cornell E, Hsing AW, Kaplan RC, Anastos K, Rajpathak S, Ho GY. Detectability and reproducibility of plasma levels of chemokines and soluble receptors. Results in Immunology. 3: 79-84. PMID 24600562 DOI: 10.1016/j.rinim.2013.07.001 |
0.134 |
|
| 2015 |
Fram EB, Agalliu I, DiVito J, Hoenig DM, Stern JM. The visceral fat compartment is independently associated with changes in urine constituent excretion in a stone forming population. Urolithiasis. 43: 213-20. PMID 25903669 DOI: 10.1007/s00240-015-0770-8 |
0.121 |
|
| 2024 |
Tanner TI, Agalliu I, Wahezi DM, Rubinstein T. Relationship of ultraviolet light exposure and cutaneous and systemic disease activity in youth with childhood-onset systemic lupus: Results from the Childhood Arthritis and Rheumatology Research Alliance Registry. Research Square. PMID 38260281 DOI: 10.21203/rs.3.rs-3777774/v1 |
0.119 |
|
| 2022 |
Xue X, Saeed O, Castagna F, Jorde UP, Agalliu I. The analysis of COVID-19 in-hospital mortality: A competing risk approach or a cure model? Statistical Methods in Medical Research. 9622802221106300. PMID 35711169 DOI: 10.1177/09622802221106300 |
0.117 |
|
| 2022 |
Tellechea LM, Freeman S, Agalliu I, Laudano MA, Suadicani SO, Abraham N. A Feasibility Study to Evaluate Changes in Urinary Metabolites after OnabotulinumtoxinA Injection for Refractory Overactive Bladder. Metabolites. 12. PMID 36144284 DOI: 10.3390/metabo12090880 |
0.115 |
|
| 2018 |
Schoenfeld D, Mohn L, Agalliu I, Stern J. 2514 Disparities in care among patients presenting to the emergency department for nephrolithiasis Journal of Clinical and Translational Science. 2: 69-69. DOI: 10.1017/CTS.2018.250 |
0.114 |
|
| 2023 |
Liu Kot K, Labagnara K, Kim JI, Loloi J, Gupta K, Agalliu I, Small AC. Evaluating the American Urologic Association (AUA) dietary recommendations for kidney stone management using the National Health And Nutritional Examination Survey (NHANES). Urolithiasis. 51: 60. PMID 36976362 DOI: 10.1007/s00240-023-01423-9 |
0.111 |
|
| 2017 |
Xue X, Agalliu I, Kim MY, Wang T, Lin J, Ghavamian R, Strickler HD. New methods for estimating follow-up rates in cohort studies. Bmc Medical Research Methodology. 17: 155. PMID 29191174 DOI: 10.1186/s12874-017-0436-z |
0.105 |
|
| 2019 |
Schoenfeld D, Mohn L, Agalliu I, Stern JM. Disparities in care among patients presenting to the emergency department for urinary stone disease. Urolithiasis. PMID 31025079 DOI: 10.1007/s00240-019-01136-y |
0.105 |
|
| 2019 |
Stern JM, Urban-Maldonado M, Usyk M, Granja I, Schoenfeld D, Davies KP, Agalliu I, Asplin J, Burk R, Suadicani SO. Fecal transplant modifies urine chemistry risk factors for urinary stone disease. Physiological Reports. 7: e14012. PMID 30789675 DOI: 10.14814/phy2.14012 |
0.104 |
|
| 2016 |
Stern JM, Moazami S, Qiu Y, Kurland I, Chen Z, Agalliu I, Burk R, Davies KP. Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers. Urolithiasis. PMID 27115405 DOI: 10.1007/s00240-016-0882-9 |
0.101 |
|
| 2012 |
Lee EW, Marien T, Laze J, Agalliu I, Lepor H. Comparison of health-related quality-of-life outcomes for African-American and Caucasian-American men after radical prostatectomy. Bju International. 110: 1129-33. PMID 22429893 DOI: 10.1111/j.1464-410X.2012.10951.x |
0.1 |
|
| 2020 |
Saeed O, Castagna F, Agalliu I, Xue X, Patel SR, Rochlani Y, Kataria R, Vukelic S, Sims DB, Alvarez C, Rivas-Lasarte M, Garcia MJ, Jorde UP. Statin Use and In-Hospital Mortality in Diabetics with COVID-19. Journal of the American Heart Association. e018475. PMID 33092446 DOI: 10.1161/JAHA.120.018475 |
0.099 |
|
| 2013 |
Zhou T, Watts K, Agalliu I, DiVito J, Hoenig DM. Effects of visceral fat area and other metabolic parameters on stone composition in patients undergoing percutaneous nephrolithotomy. The Journal of Urology. 190: 1416-20. PMID 23685097 DOI: 10.1016/j.juro.2013.05.016 |
0.097 |
|
| 2012 |
Mass AY, Agalliu I, Laze J, Lepor H. Preoperative statin therapy is not associated with biochemical recurrence after radical prostatectomy: our experience and meta-analysis. The Journal of Urology. 188: 786-91. PMID 22818136 DOI: 10.1016/j.juro.2012.05.011 |
0.088 |
|
| 2011 |
Hakimi AA, Faleck DM, Agalliu I, Rozenblit AM, Chernyak V, Ghavamian R. Preoperative and intraoperative measurements of urethral length as predictors of continence after robot-assisted radical prostatectomy. Journal of Endourology / Endourological Society. 25: 1025-30. PMID 21568755 DOI: 10.1089/end.2010.0692 |
0.072 |
|
| 2015 |
Tabung FK, Steck SE, Zhang J, Ma Y, Liese AD, Agalliu I, Hingle M, Hou L, Hurley TG, Jiao L, Martin LW, Millen AE, Park HL, Rosal MC, Shikany JM, et al. Construct validation of the dietary inflammatory index among postmenopausal women. Annals of Epidemiology. 25: 398-405. PMID 25900255 DOI: 10.1016/J.Annepidem.2015.03.009 |
0.067 |
|
| 2022 |
Yoon H, Wake RM, Nakouzi AS, Wang T, Agalliu I, Tiemessen CT, Govender NP, Jarvis JN, Harrison TS, Pirofski LA. The association of antibody immunity with cryptococcal antigenemia and mortality in a South African cohort with advanced HIV disease. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35915964 DOI: 10.1093/cid/ciac633 |
0.066 |
|
| 2012 |
Djavan B, Agalliu I, Laze J, Sadri H, Kazzazi A, Lepor H. Blood loss during radical prostatectomy: impact on clinical, oncological and functional outcomes and complication rates. Bju International. 110: 69-75. PMID 22145995 DOI: 10.1111/j.1464-410X.2011.10812.x |
0.066 |
|
| 2023 |
Brathwaite KE, Levy RV, Sarathy H, Agalliu I, Johns TS, Reidy KJ, Fadrowski JJ, Schwartz GJ, Kaskel FJ, Melamed ML. Reduced kidney function and hypertension in adolescents with low birth weight, NHANES 1999-2016. Pediatric Nephrology (Berlin, Germany). PMID 37052695 DOI: 10.1007/s00467-023-05958-2 |
0.066 |
|
| 2016 |
Cutforth T, DeMille MM, Agalliu I, Agalliu D. CNS autoimmune disease after Streptococcus pyogenes infections: animal models, cellular mechanisms and genetic factors. Future Neurology. 11: 63-76. PMID 27110222 DOI: 10.2217/Fnl.16.4 |
0.064 |
|
| 2021 |
Mckay ER, Davila JL, Lee JA, Rolston R, Agalliu I, Abraham NE. Representation of Minority Groups in Key Pelvic Floor Disorder Trials. Female Pelvic Medicine & Reconstructive Surgery. 27: 602-608. PMID 34554142 DOI: 10.1097/SPV.0000000000001002 |
0.055 |
|
| 2020 |
Zuo SW, English K, Agalliu I, Leegant A, Abraham N. Racial and Ethnic Differences in Urodynamic Parameters in Women With Overactive Bladder Symptoms. Female Pelvic Medicine & Reconstructive Surgery. 26: 141-145. PMID 31990803 DOI: 10.1097/SPV.0000000000000838 |
0.053 |
|
| 2022 |
Chen L, Agalliu I, Roth A, Rastogi D. Association of Fractional Exhaled Nitric Oxide with Asthma Morbidity in Urban Minority Children. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 1-17. PMID 35499408 DOI: 10.1080/02770903.2022.2073549 |
0.048 |
|
| 2013 |
Ioffe E, Hakimi AA, Oh SK, Agalliu I, Ginzburg N, Williams SK, Kao L, Rozenblit AM, Ghavamian R. Effect of visceral obesity on minimally invasive partial nephrectomy. Urology. 82: 612-8. PMID 23987153 DOI: 10.1016/j.urology.2013.04.058 |
0.044 |
|
| 2015 |
Silver AH, Esteban-Cruciani N, Azzarone G, Douglas LC, Lee DS, Liewehr S, Nazif JM, Agalliu I, Villegas S, Rhim HJ, Rinke ML, O'Connor K. 3% Hypertonic Saline Versus Normal Saline in Inpatient Bronchiolitis: A Randomized Controlled Trial. Pediatrics. PMID 26553190 DOI: 10.1542/Peds.2015-1037 |
0.04 |
|
| 2020 |
Solouki S, Vega M, Agalliu I, Abraham NE. Patient Satisfaction and Refill Rates After Decreasing Opioids Prescribed for Urogynecologic Surgery. Female Pelvic Medicine & Reconstructive Surgery. PMID 32947551 DOI: 10.1097/SPV.0000000000000929 |
0.035 |
|
| 2019 |
Fritz R, Mukherjee A, Zaghi S, Agalliu I, Jindal S, Tashima AK, Fricker LD, Davies KP. Identification and characterization of RSIY-11, a novel seminal peptide derived from semenogelin-1, which acts as a neutral endopeptidase inhibitor modulating sperm motility. Journal of Assisted Reproduction and Genetics. PMID 31346917 DOI: 10.1007/s10815-019-01524-8 |
0.033 |
|
| 2012 |
Niver BE, Agalliu I, Bareket R, Mufarrij P, Shah O, Stifelman MD. Analysis of robotic-assisted laparoscopic pyleloplasty for primary versus secondary repair in 119 consecutive cases. Urology. 79: 689-94. PMID 22386423 DOI: 10.1016/j.urology.2011.10.072 |
0.032 |
|
| 2009 |
Agalliu I, Schweitzer PA, Leanza SM, Burk RD, Rohan TE. Illumina DNA test panel-based genotyping of whole genome amplified-DNA extracted from hair samples: performance and agreement with genotyping results from genomic DNA from buccal cells. Clinical Chemistry and Laboratory Medicine. 47: 516-22. PMID 19397482 DOI: 10.1515/CCLM.2009.106 |
0.032 |
|
| 2018 |
Solouki S, Plummer M, Agalliu I, Abraham N. Opioid prescribing practices and medication use following urogynecological surgery. Neurourology and Urodynamics. PMID 30431173 DOI: 10.1002/nau.23867 |
0.032 |
|
| 2020 |
Moazami S, Davuluri M, Srivastava A, Agalliu I, Maria P. 396 The Use of Oxidized Cellulose and Fibrin Sealant to Prevent Infection Following Penile Prosthesis Insertion The Journal of Sexual Medicine. 17: S113-S114. DOI: 10.1016/j.jsxm.2019.11.240 |
0.028 |
|
| 2024 |
Hossain OB, Srikantha R, Ferguson N, Agalliu I, Gonzalez CM. Implicit Bias and Clinical Decision Making in Psoriasis Management Among Dermatology Residents: A Feasibility Study. Journal of Drugs in Dermatology : Jdd. 23: e73-e76. PMID 38306135 DOI: 10.36849/JDD.7499 |
0.019 |
|
| 2017 |
Lengfeld JE, Lutz SE, Smith JR, Diaconu C, Scott C, Kofman SB, Choi C, Walsh CM, Raine CS, Agalliu I, Agalliu D. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 28137846 DOI: 10.1073/Pnas.1609905114 |
0.018 |
|
| 2009 |
Agalliu D, Takada S, Agalliu I, McMahon AP, Jessell TM. Motor neurons with axial muscle projections specified by Wnt4/5 signaling. Neuron. 61: 708-20. PMID 19285468 DOI: 10.1016/J.Neuron.2008.12.026 |
0.018 |
|
| 2015 |
Keehn A, Maiman R, Agalliu I, Taylor J, Ghavamian R. Outcomes and Management Considerations in Patients on Dialysis Undergoing Laparoscopic Radical Nephrectomy for Renal-Cell Carcinoma. Journal of Endourology / Endourological Society. 29: 691-5. PMID 25423552 DOI: 10.1089/end.2014.0484 |
0.015 |
|
| Hide low-probability matches. |